An international team of researchers, led by PopData Scientific Director, Kimberlyn McGrail, has been awarded a $413,000 grant from the Canadian Institutes of Health Research to compare traditional with new privacy preserving linkage techniques.   

Data access has been approved for a team at BC Cancer to evaluate the effectiveness of the drug Bevacizumab (Avastin) in the treatment of metastatic colorectal cancer.

PopData will link data from BC Cancer with BC Ministry of Health and BC Vital Statistics data for the project.

Data access has been approved for Phase Two of a project to improve planning for mental health and substance use services in British Columbia.

The coordination of long-term, follow-up care for young cancer survivors is critical to providing continuing care that is both effective for the survivor, and efficient for the health care system.

Arrhythmia is a condition in which the heart beats with an irregular or abnormal rhythm. Atrial fibrillation, the most common clinically significant arrhythmia, affects over 400,000 Canadians, and is a potent independent risk factor for thromboembolism, particularly stroke.

Rheumatic diseases are the most common source of severe pain and disability in Canada, and have wide-ranging impacts on peoples' lives including their health-related quality of life, ability to work, financial situation, and use of the health care system.

Personalized medicine, the tailoring of care based on individual characteristics, has grown rapidly in recent years, particularly for cancer treatment.